THE PHENOTYPIC AND FUNCTIONAL-CHANGES OF RAT KUPFFER CELLS CULTURED WITH INTERLEUKIN-2

被引:5
作者
INOUE, S
YAMASHITA, A
机构
[1] Kanzakigawa Laboratory, Shionogi Research Laboratories, Shionogi & Co., Ltd., 3-1-1, Futaba-cho
[2] 2nd Department of Anatomy, Hamamatsu University School of Medicine, 3600, Handa-cho
关键词
MACROPHAGE ANTIGEN; CLASS; 2; ANTIGEN; FC RECEPTOR; COMPLEMENT RECEPTOR; PHAGOCYTOSIS; ACCESSORY CELL FUNCTION;
D O I
10.1177/019262339302100109
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We examined the direct effects of human recombinant interleukin 2 (hrIL-2) in vitro on the PhenotYpic and the functional changes of rat Kupffer cells (KCs) isolated by collagenase perfusion and differential centrifugation. When KCs were cultured with high concentrations of hrIL-2, marked changes were dose-dependently observed in phenotypic expression, phagocytic activity, and accessory cell function compared to untreated KCs. In the phenotypic changes, approximately 70% of KCs expressed class 2 antigen after 48-hr culture. Moreover, rapid expression of iC3b receptor on KCs was observed after 6 hr culture. KC phagocytic activity of both 0.81- and 2-mum latex particles was increased by incubating with hrIL-2 (10(4)U/ml) as compared to those of untreated KCs. Complement-mediated phagocytosis was more dominant than that of Fc receptor-mediated phagocytosis without hrIL-2 and augmented by increasing concentrations of hrIL-2. Accessory cell function of KCs was greatly augmented by preincubation with hrIL-2 (10(4) U/ml) for 24 hr. In the presence of 10(-6) m of indomethacin or prostaglandin E2, accessory cell function was at a lower level than without. This suppressive effect of indomethacin or prostaglandin E2 was reduced at lower concentrations. These results suggest that the potential ability of hrIL-2-activated KCs is closely associated with the ongoing pathophysiological process in the liver during IL-2 immunotherapy.
引用
收藏
页码:71 / 80
页数:10
相关论文
共 27 条
[1]  
Anderson T.D., Hayes T.J., Toxicity of human recombinant interleukin-2 in rats. Pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multisystem involvement, Lab. Invest, 60, pp. 331-346, (1989)
[2]  
Aronson F.R., Libby P., Brandon E.P., Janicka M.W., Mier J.W., IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury, J. Immunol, 141, pp. 158-163, (1988)
[3]  
Blay J.Y., Bertoglio J., Fradelizi D., Chouaib S., Functional interactions of IL-2 and TNF in the differentiation of LGL into LAK effectors, Int. J. Cancer, 44, pp. 598-604, (1989)
[4]  
Chang A.E., Hyatt C.L., Rosenberg S.A., Systemic administration of recombinant human interleukin-2 in mice, J. Biol. Response Mod, 3, pp. 561-572, (1984)
[5]  
Curran R.D., Billiar T.R., West M.A., Bentz B.G., Simmons R.L., Effect of interleukin-2 on Kupffer cell activation. Interleukin-2 primes and activates Kupffer cells to suppress hepatocyte protein synthesis in vitro, Arch. Surg, 123, pp. 1373-1378, (1988)
[6]  
Decker K., Review: Biologically active products of stimulated liver macrophages (Kupffer cells), Eur. J. Biochem, 192, pp. 245-261, (1990)
[7]  
Decker T., Lohmann-Matthes M.L., Karck U., Peters T., Decker K., Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages, J. Leukoc. Biol, 45, pp. 139-146, (1989)
[8]  
Economou J.S., McBride W.H., Essner R., Rhoades K., Golub S., Holmes E.C., Morton D.L., Tumour necrosis factor production by IL-2 activated macrophages in vitro and in vivo, Immunology, 67, pp. 514-519, (1989)
[9]  
Gaillard T., Mulsch A., Busse R., Klein H., Decker K., Regulation of nitric oxide production by stimulated rat Kupffer cells, Pathobiology, 59, pp. 280-283, (1991)
[10]  
Goodwin J.S., Webb D.R., Regulation of the immune response by prostaglandins, Clin. Immunol. Immunopathol, 15, pp. 106-122, (1980)